Announcements Trials

Browse Landscape

Phase

Phase 2 1 Phase 1/2 1

Status

Sponsor Class

OTHER 4 INDUSTRY 3 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 1

Interventions

Radiotherapy 13 Cisplatin 8 Cytarabine 7 carfilzomib 5 Specimen Handling 5 Paclitaxel 5 Dexamethasone 5 Methotrexate 4 Lapatinib 4 Gemcitabine 4 Fluorouracil 4 Docetaxel 4 Brachytherapy 4 Biopsy 4 venetoclax 3 pomalidomide 3 Temozolomide 3 Radiotherapy, Conformal 3 Leucovorin 3 Irinotecan 3 Etoposide 3 Cyclophosphamide 3 Carboplatin 3 neratinib 2 merphos 2 Vincristine 2 Radiation 2 Polymerase Chain Reaction 2 Oxaliplatin 2 Immunohistochemistry 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × NETWORK × enasidenib × Clear all

NCT03732703 2025-02-14

MyDRUG

Multiple Myeloma Research Consortium

Phase 1/2 Completed

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡